Bourg la Reine, France

Michel Dron

This inventor holds 1 USPTO granted patent. Top assignee: Pharma Pacific Pty. Ltd.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michel Dron. Retrieved from https://idiyas.com/inventor/michel-dron

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michel Dron: Innovator in Interferon Research

Introduction

Michel Dron is a notable inventor based in Bourg la Reine, France. He has made significant contributions to the field of biotechnology, particularly in the area of interferon research. His work focuses on the identification and therapeutic applications of proteins responsive to interferon alpha.

Latest Patents

Michel Dron holds a patent for an invention titled "Interferon alpha responsive protein." This invention relates to the identification of a gene that is upregulated by interferon-alpha administration. The corresponding cDNA sequence is set forth in SEQ ID NO: 1. The determination of expression products of this gene is proposed to have utility in predicting responsiveness to treatment with interferon-alpha and other interferons that act at the Type 1 interferon receptor. Additionally, the therapeutic use of the protein encoded by this gene is also envisaged.

Career Highlights

Michel Dron is associated with Pharma Pacific Pty. Ltd., where he continues to advance his research and development efforts. His work has the potential to impact the treatment of various diseases through the modulation of interferon responses.

Collaborations

Some of his notable coworkers include Michael Gerard Tovey and Jean-François Meritet. Their collaborative efforts contribute to the innovative research environment at Pharma Pacific Pty. Ltd.

Conclusion

Michel Dron's contributions to interferon research exemplify the importance of innovation in biotechnology. His patent and ongoing work highlight the potential for new therapeutic approaches in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…